Company: LRHC
Filing Date: 2025-10-28
Form Type: DEF 14A
Source: 0001213900-25-102781
Chunk: 39

Company: La Rosa Holdings Corp.
Filing Date: 2025-10-28
Form: DEF 14A
Chunk 39
---
 year, the maximum aggregate number of shares of common stock which may be issued pursuant to awards under the Second Amended 2022 Plan is 374,961 shares. Such shares of common stock are made available from the authorized and unissued shares of the Company. If shares of common stock subject to an option or performance award granted under the Second Amended 2022 Plan expire or otherwise terminate without being exercised (or exercised in full), such shares will become available again for grants under the Second Amended 2022 Plan. If shares of restricted stock awarded under the Second Amended 2022 Plan are forfeited to us or repurchased by us, the number of shares forfeited or repurchased shall not again be available under the Second Amended 2022 Plan. Similarly, any shares cancelled in cashless exercises are not available for re-issuance under the Second Amended 2022 Plan. The Company cannot determine the amounts of awards that will be granted or allocated under the Second Amended 2022 Plan or the benefits of any awards to the executive officers and directors of the Company or employees who are not executive officers as a group. Under the terms of the Second Amended 2022 Plan, the number of awards to be granted is within the discretion of the Compensation Committee. The Compensation Committee may issue options, shares of restricted stock, restricted stock units or other awards under the Second Amended 2022 Plan for such consideration as determined in their sole discretion, subject to applicable law. As of the Record Date, we have issued 54,155 options, 304,520 shares of restricted stock, and 14,332 restricted stock units, to certain of our agents, consultants and employees under our equity incentive plan. Pricing; Vesting; Expiration.The Compensation Committee, in its sole discretion, will determine the exercise price of any options granted under the Second Amended 2022 Plan which exercise price will be outlined in an agreement evidencing the option, provided, however, that at no time will the exercise price be less than the par value per share of the Company’s common stock. Also, the exercise price of incentive stock options may not be less than the fair market value of the common stock subject to the option on the date of the grant and, in some cases, may not be less than 110% of such fair market value. The exercise price of non-statutory options may not be less than the common stock’s fair market value on the grant date. The exercise price of options granted under the